XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 167,335 $ 185,000
Accounts receivable, net 16,357 15,148
Inventory, net 7,138 6,114
Prepaid expenses and other current assets 2,822 3,415
Total current assets 193,652 209,677
Property and equipment, net 1,393 1,571
Operating lease right-of-use assets 1,372 1,614
Other noncurrent assets 224 211
Total assets 196,641 213,073
Current liabilities:    
Accounts payable 3,501 2,688
Accrued compensation 4,958 7,352
Accrued and other current liabilities 6,686 7,777
Total current liabilities 15,145 17,817
Long-term debt 33,457 33,313
Other noncurrent liabilities 1,663 1,867
Total liabilities 50,265 52,997
Commitments and contingencies (Note 6)
Stockholders' equity:    
Preferred stock par value of $0.001 per share; 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 0 0
Common stock par value of $0.001 per share; 200,000,000 shares authorized as of March 31, 2023 and December 31, 2022, respectively; 48,450,378 and 48,298,138 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 48 48
Additional paid-in-capital 402,638 399,271
Accumulated deficit (256,310) (239,243)
Total stockholders' equity 146,376 160,076
Total liabilities and stockholders' equity $ 196,641 $ 213,073